| Dr Maheshwer B Verma, MD | |
|
21 Corporate Dr, Suite #4, Easton, PA 18045-2664 | |
| (610) 252-4220 | |
| (610) 258-2553 |
| Full Name | Dr Maheshwer B Verma |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 21 Corporate Dr, Easton, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235121146 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD 026487-E (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Maheshwer B Verma, MD 21 Corporate Dr, Suite #4, Easton, PA 18045-2664 Ph: (610) 252-4220 | Dr Maheshwer B Verma, MD 21 Corporate Dr, Suite #4, Easton, PA 18045-2664 Ph: (610) 252-4220 |
News Archive
In earlier studies, researchers at Louisiana State University had found that estrogen - or more precisely, having ovaries - made adult rats exposed for the first time to THC, the primary ingredient in marijuana and hashish, less sensitive to THC's negative effects on tests of learning and memory.
Marking International Women's Day at the White House Monday, President Barack Obama vowed to fight for gender equality at home and abroad, Agence France-Presse reports. The president marked the event with First Lady Michelle Obama, Secretary of State Hillary Rodham Clinton and former Secretary of State Madeleine Albright, AFP reports.
Nile Therapeutics, Inc. a biopharmaceutical company focused on the development of novel therapeutics for cardiovascular disease, today announced results of its Phase 2 study evaluating its lead compound CD-NP in patients with acute decompensated heart failure (ADHF) and mild to moderate renal insufficiency. Study results demonstrated that multiple doses were characterized as well tolerated with favorable drug activity in this acute patient population.
Badri Roysam, chair of the University of Houston Department of Electrical and Computer Engineering, is leading a $3.19 million project to create new technology that could provide an unprecedented look at the injured brain.
Shire plc, the global specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) approved Lialda® (mesalamine) Delayed Release Tablets for the maintenance of remission in patients with ulcerative colitis.
› Verified 5 days ago
Mahima Tibrewal, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1872 St Lukes Blvd, Easton, PA 18045 Phone: 484-526-0000 | |
Patricia A Geil, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2925 William Penn Hwy, Suite 201, Easton, PA 18045 Phone: 610-258-1400 Fax: 610-258-3047 | |
Ahmad M Atiyeh, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 325 Pine Street, Easton, PA 18042 Phone: 610-253-1460 Fax: 610-253-1830 | |
Sahar Fooladi, Pediatrics Medicare: Medicare Enrolled Practice Location: 2401 Northampton St Ste 210, Easton, PA 18045 Phone: 484-591-7470 | |
Hui C Lee, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2401 Northampton St Ste 210, Easton, PA 18045 Phone: 484-591-7470 | |
Anita T Shah, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2200 St Luke's Blvd, Physician Billing, Easton, PA 18045 Phone: 484-503-0060 |